1. |
Lara AR, Schwarz MI. Diffuse alveolar hemorrhage. Chest, 2010, 137(5): 1164-1171.
|
2. |
夏瑜, 王宇翀, 薛春雨. 血管肉瘤的研究进展. 中国美容整形外科杂志, 2020, 31(4): 227-229.
|
3. |
Ishida Y, Otsuka A, Kabashima K. Cutaneous angiosarcoma: update on biology and latest treatment. Curr Opin Oncol, 2018, 30(2): 107-112.
|
4. |
王汉萍, 施举红, 王文泽, 等. 以弥漫性肺泡出血为首发表现的肺转移性血管肉瘤九例分析. 中华内科杂志, 2018, 57(8): 582-587.
|
5. |
Chen MQ, Lu WL, Wu SG, et al. Metagenomic next-generation sequencing in the diagnosis of leptospirosis presenting as severe diffuse alveolar hemorrhage: a case report and literature review. BMC Infect Dis, 2021, 21(1): 1230.
|
6. |
Park MS. Diffuse alveolar hemorrhage. Tuberc Respir Dis (Seoul), 2013, 74(4): 151-162.
|
7. |
de Prost N, Parrot A, Picard C, et al. Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality. Eur Respir J, 2010, 35(6): 1303-1311.
|
8. |
陈光星, 董怡, 鞠中斌. 弥漫性结缔组织病并发弥漫性肺泡出血32例临床分析. 中华内科杂志, 2008, 47(5): 362-365.
|
9. |
辛庆红, 张文博, 李继成, 等. 17例弥漫性肺泡出血临床分析. 中国呼吸与危重监护杂志, 2010, 9(6): 624-626.
|
10. |
方芳, 李燕明, 胡松涛, 等. 弥漫性肺泡出血的临床和病理学特征. 中华医学杂志, 2016, 96(2): 108-112.
|
11. |
薛晓艳, 徐钰, 陈永立, 等. 弥漫性肺泡出血31例临床分析. 中国急救医学, 2013, 33(3): 231-234.
|
12. |
沈吉林, 谢兴宇. 感染相关性弥漫性肺泡出血综合征1例报告. 贵州医药, 2018, 42(2): 224-225.
|
13. |
阮航, 简竹, 王迎难, 等. 弥漫性肺泡出血. 中华结核和呼吸杂志, 2021, 44(11): 1019-1020.
|
14. |
刘毅, 郑培浩, 岑坚, 等. 21例继发于血液系统疾病的弥漫性肺泡出血分析. 解放军医学院学报, 2015, 36(5): 447-450.
|
15. |
Higo H, Suzaki N, Nagata T, et al. Pulmonary lymphangitic carcinomatosis from gallbladder cancer mimicking diffuse alveolar haemorrhage. Respirol Case Rep, 2020, 8(3): e540.
|
16. |
Lichtenberger JP 3rd, Digumarthy SR, Abbott GF, et al. Diffuse pulmonary hemorrhage: clues to the diagnosis. Curr Probl Diagn Radiol, 2014, 43(3): 128-139.
|
17. |
翟吉良, 张保中, 唐璜. 成人Kasabach-Merritt综合征1例报道. 中华骨与关节外科杂志, 2015, 8(5): 444-446.
|
18. |
Florou V, Wilky BA. Current management of angiosarcoma: recent advances and lessons from the past. Curr Treat Options Oncol, 2021, 22(7): 61.
|
19. |
龚毓宾, 孙斌, 雷红召, 等. Kasabach-Merritt现象的研究进展和治疗. 中华实用儿科临床杂志, 2014, 29(10): 789-791.
|
20. |
Yao W, Li KL, Qin ZP, et al. Standards of care for Kasabach-Merritt phenomenon in China. World J Pediatr, 2021, 17(2): 123-130.
|
21. |
Mahajan P, Margolin J, Iacobas I. Kasabach-Merritt phenomenon: classic presentation and management options. Clin Med Insights Blood Disord, 2017, 10: 1179545X17699849X.
|
22. |
Young RJ, Natukunda A, Litière S, et al. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials. Eur J Cancer, 2014, 50(18): 3178-3186.
|
23. |
周江元, 杨开颖, 彭素华, 等. 西罗莫司联合泼尼松治疗卡波西样血管内皮瘤伴Kasabach-Merritt现象初探. 中华皮肤科杂志, 2020, 53(7): 514-518.
|